Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk, Predictors, and Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Egypt.

Scientific reports·2017

Same author

Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.

Cardiorenal medicine·2017

Same author

Obesity and kidney disease: Hidden consequences of the epidemic.

African journal of primary health care & family medicine·2017

Same author

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2017

Same author

Optimizing hypertension management in renal transplantation: a call to action.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2017

Same author

Optimizing hypertension management in renal transplantation: a call to action.

Journal of hypertension·2017

Search research articles

Related Experiment Video

Updated: May 16, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Prognostic models in the clinical arena.

Davide Bolignano¹, Francesco Mattace-Raso, Claudia Torino

¹CNR-IBIM, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Reggio Calabria, Italy. davide.bolignano@gmail.com

Aging Clinical and Experimental Research

|December 15, 2012

Summary

Prognostic models predict disease outcomes using mathematical equations. Evaluating their generalizability and accuracy through discrimination, calibration, and reclassification is crucial for reliable clinical predictions.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: May 16, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

Medical Statistics
Clinical Epidemiology
Biostatistics

Background:

Prognosis involves predicting disease course and outcome risks based on patient characteristics.
Multivariable mathematical equations, known as prognostic models, are commonly used for prognostic assessment.

Purpose of the Study:

To define prognostic models and outline methods for constructing effective ones.
To emphasize the importance of evaluating prognostic model generalizability and accuracy.

Main Methods:

Describing the fundamental principles of prognostic model development.
Explaining key evaluation metrics: discrimination, calibration, and reclassification.

Main Results:

Prognostic models are essential tools for predicting clinical outcomes.
Rigorous evaluation ensures the reliability and applicability of these models across different populations.

Conclusions:

Understanding prognostic model construction and evaluation is vital for evidence-based medicine.
Accurate and generalizable prognostic models improve clinical decision-making and patient care.